LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20 | – | 5,000 | +1566.7% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 300 | -75.0% | 0.00% | – |
Q1 2023 | $1 | -98.1% | 1,200 | -94.4% | 0.00% | -100.0% |
Q4 2022 | $52 | -99.9% | 21,296 | +6.5% | 0.01% | 0.0% |
Q3 2022 | $67,000 | -82.5% | 20,000 | -18.7% | 0.01% | -81.5% |
Q2 2022 | $382,000 | +496.9% | 24,600 | +82.2% | 0.03% | +575.0% |
Q1 2022 | $64,000 | – | 13,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |